Regenerative medicine is a discipline of medicine that focuses on the repair or replacement of damaged or diseased cells or tissues. Many institutions are developing novel methods to use naturally occurring cells, transgenic cells, derived cellular products, or engineered products to affect the repair or replacement process. Xeno Dx has been involved with testing services of umbilical derived CD34+ cells, MSCs, and novel biologically derived products throughout the discovery, development, and application of these in the regenerative process.
Flow cytometry testing for viability and percent quantitation of umbilical derived CD34+ cells for cord blood banking services or research.
We assist clients who are developing MSC based products through flow cytometric based phenotyping.
Client articles are tested in one-way or two-way MLR using PBMCs from Xeno Diagnostic’s human donor bank. Client articles tested include engineered cardiomyocytes, porcine cells, macrophages, mesenchymal stem cells, bone materials, and Wharton’s jelly.
Please call or email if you have an idea for a custom project that utilizes our technical capacity or a similar idea/modification to the assays above. We are a fully equipped research lab with immunological technical expertise.
Technical Capacity/Technologies Utilized:
Copyright © 2021. All rights reserved.
